GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » Total Assets

Nextbiomedical Co (XKRX:389650) Total Assets : ₩29,643 Mil (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Nextbiomedical Co Total Assets?

Nextbiomedical Co's Total Assets for the quarter that ended in Dec. 2023 was ₩29,643 Mil.

During the past 12 months, Nextbiomedical Co's average Total Assets Growth Rate was -11.40% per year. During the past 3 years, the average Total Assets Growth Rate was -4.90% per year.

During the past 4 years, Nextbiomedical Co's highest 3-Year average Total Assets Growth Rate was -4.90%. The lowest was -4.90%. And the median was -4.90%.

Total Assets is connected with ROA %. Nextbiomedical Co's annualized ROA % for the quarter that ended in Dec. 2023 was -24.35%. Total Assets is also linked to Revenue through Asset Turnover. Nextbiomedical Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.16.

Nextbiomedical Co Total Assets Historical Data

The historical data trend for Nextbiomedical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextbiomedical Co Total Assets Chart

Nextbiomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Assets
24,590.82 39,720.13 32,135.74 29,643.39

Nextbiomedical Co Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Total Assets 24,590.82 39,720.13 32,135.74 29,643.39

Nextbiomedical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Nextbiomedical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=-5901+35544.392
=29,643

Nextbiomedical Co's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=-5901+35544.392
=29,643

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nextbiomedical Co  (XKRX:389650) Total Assets Explanation

Total Assets is connected with ROA %.

Nextbiomedical Co's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Dec. 2023 ))/ count )
=-7521.513/( (32135.74+29643.392)/ 2 )
=-7521.513/30889.566
=-24.35 %

Note: The Net Income data used here is one times the annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Nextbiomedical Co's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Dec. 2023 ))/ count )
=4882.233/( (32135.74+29643.392)/ 2 )
=4882.233/30889.566
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Nextbiomedical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Nextbiomedical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextbiomedical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » Total Assets
Comparable Companies
Traded in Other Exchanges
N/A
Address
Venture-ro, No. 6, 100 beongil, Yeonsu-gu, Incheon, KOR
Website
https://www.nextbiomedical.co.kr/kr
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.

Nextbiomedical Co Headlines

No Headlines